Caricamento...
LDL Cholesterol, Statins And PCSK 9 Inhibitors
Reduction of low density lipoprotein cholesterol (LDLc) is of vital importance for the prevention of atherosclerotic cardiovascular disease (ASCVD). Statin is the most effective therapy today to lower LDLc by inhibiting HMG-CoA-reductase. However despite intensive statin therapy, there remains a res...
Salvato in:
| Pubblicato in: | Indian Heart J |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593843/ https://ncbi.nlm.nih.gov/pubmed/26432726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.05.020 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|